Post by sharksrog on Nov 2, 2021 20:47:11 GMT -5
There’s a “strong” chance that the Giants will push to work out a multi-year deal to keep Kevin Gausman atop their rotation, per Susan Slusser of the San Francisco Chronicle. The Giants value the chemistry that was developed during this year’s postseason push and have interest in maintaining some continuity, which could lead them to explore reunions with any of Gausman, Anthony DeSclafani and Alex Wood. San Francisco president of baseball operations Farhan Zaidi has already gone on record to call the rotation the team’s “number one priority” this offseason, no surprise given the impending free agencies of Gausman, DeSclafani, Wood and Johnny Cueto (whose $22MM club option will assuredly be bought out for $5MM). The Giants have about as much payroll flexibility as any team in baseball, giving Zaidi and his staff myriad options in rebuilding the rotation over the coming months. It certainly stands to reason they’ll be active in the market for Gausman, who has an even 3.00 ERA with stellar strikeout and walk numbers (30% and 6.5%, respectively) over 251 2/3 innings in black and orange since the start of 2020.
Gausman received a qualifying offer last winter, making him ineligible for another in his career. The Giants will have to decide whether to offer an $18.4MM QO to one or both of DeSclafani and Wood in the coming days, though. Grant Brisbee of the Athletic opines the club should offer a QO to DeSclafani based on the aforementioned rotation uncertainty and payroll flexibility. Signed to a bounceback deal last offseason following a poor 2020 with the Reds, DeSclafani made 31 starts and worked 167 2/3 innings of 3.17 ERA/4.11 SIERA ball this past season. Brisbee doesn’t expect San Francisco to risk that lofty one-year sum on a QO for Wood, however. Also a low-cost flier last winter, Wood impressed with 138 2/3 frames with a 3.83 ERA/3.60 SIERA. Injuries limited the veteran southpaw to just 48 1/3 combined innings from 2019-20, though, and it remains to be seen how much of an effect durability concerns could have on Wood’s free agent market this time around.
As I have already posted, I"m with Grant on this one. I like Wood better than DeSclafani, but because of his health issues I don't think I would risk a QO. If I were Wood, I would be highly tempted to accept a QO if one were made and then try to build a healthy, successful 2022 so that without a team next winter having to worry about any compensation requirements for signing me, I might be able to build a long-term contract. I would love to see the Giants re-sign Alex, but I think it would be too risky to go too high or too long.
Then again, they know much more medically about him than I.
Gausman received a qualifying offer last winter, making him ineligible for another in his career. The Giants will have to decide whether to offer an $18.4MM QO to one or both of DeSclafani and Wood in the coming days, though. Grant Brisbee of the Athletic opines the club should offer a QO to DeSclafani based on the aforementioned rotation uncertainty and payroll flexibility. Signed to a bounceback deal last offseason following a poor 2020 with the Reds, DeSclafani made 31 starts and worked 167 2/3 innings of 3.17 ERA/4.11 SIERA ball this past season. Brisbee doesn’t expect San Francisco to risk that lofty one-year sum on a QO for Wood, however. Also a low-cost flier last winter, Wood impressed with 138 2/3 frames with a 3.83 ERA/3.60 SIERA. Injuries limited the veteran southpaw to just 48 1/3 combined innings from 2019-20, though, and it remains to be seen how much of an effect durability concerns could have on Wood’s free agent market this time around.
As I have already posted, I"m with Grant on this one. I like Wood better than DeSclafani, but because of his health issues I don't think I would risk a QO. If I were Wood, I would be highly tempted to accept a QO if one were made and then try to build a healthy, successful 2022 so that without a team next winter having to worry about any compensation requirements for signing me, I might be able to build a long-term contract. I would love to see the Giants re-sign Alex, but I think it would be too risky to go too high or too long.
Then again, they know much more medically about him than I.
